CHOP is an academic medical center with a track record of excellence in pediatric research, including discovery of cures for pediatric illnesses. Our team helps programs across the enterprise obtain government support and resources to advance innovation in pediatric care and continue to move the needle towards breakthroughs that enhance high-quality healthcare delivery for children. 

CHOP’s Research Institute is one of the nation’s largest recipients of NIH funding made available to pediatric hospitals. Approximately 2,000 investigators and research staff working in more than 821,000 square feet of laboratory space on the hospital campuses conduct research that has led to pioneering treatments and innovative technologies that are dramatically improving health outcomes for children.

NIH awards help fund this groundbreaking research, and equally importantly, the researchers themselves. Advocacy efforts are crucial in maintaining this grant funding and finding new grants to help power tomorrow’s breakthroughs.

Government Affairs also advocates at the state level for research funding, specifically the Pennsylvania Commonwealth Universal Research Enhancement Program, also known as CURE.  CURE, was established in 2001 by Act 77, funded by the tobacco settlement. CHOP researchers, including Stephan A. Grupp, MD, PhD, have been recipients of CURE funds. In fact, Dr. Grupp credits CURE dollars with contributing to his breakthrough research on treating pediatric leukemia with T-cell therapy, which is now approved by the FDA.